New radioactive cocktail aims to shrink tough prostate tumors

NCT ID NCT06855277

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This Phase 3 trial tests whether adding a radioactive drug called AAA817 to standard hormone therapy can slow cancer growth better than current treatments alone. About 940 men with PSMA-positive metastatic castration resistant prostate cancer will be randomly assigned to receive either AAA817 plus an ARPI (enzalutamide or abiraterone) or standard care. The study measures how long participants live without their cancer worsening and overall survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AAA817 (a radioactive drug that targets prostate cancer cells) plus an androgen receptor pathway inhibitor (ARPI, a hormone-blocking drug)
What this could lead to
If successful, this combination could offer a new treatment option that delays cancer progression and extends survival for men with advanced prostate cancer that has stopped responding to hormone therapy.
What could go wrong
This is an early-stage Phase 3 trial, so results are not yet known. The radioactive treatment may cause side effects like bone marrow suppression or kidney damage, and not all participants may benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AdventHealth

    RECRUITING

    Orlando, Florida, 32804, United States

  • Associated Med Professionals of NY

    RECRUITING

    Syracuse, New York, 13210, United States

  • Astera Cancer Center

    RECRUITING

    East Brunswick, New Jersey, 08816, United States

  • Baptist Health South

    RECRUITING

    Miami, Florida, 33173, United States

  • Bassett Medical Center

    RECRUITING

    Cooperstown, New York, 13326, United States

  • Beth Israel Deaconess Med Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Carolina Urologic Research Center

    RECRUITING

    Myrtle Beach, South Carolina, 29572, United States

  • Central Ohio Urology Group

    RECRUITING

    Gahanna, Ohio, 43230, United States

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • East Jefferson Hospital

    RECRUITING

    Metairie, Louisiana, 70006, United States

  • Florida Cancer Specialists

    RECRUITING

    Fort Myers, Florida, 33901, United States

  • Karmanos Cancer Institute

    RECRUITING

    Detroit, Michigan, 48201, United States

  • MUSC Hollings Cancer Center

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10461, United States

  • Nebraska Cancer Specialists

    RECRUITING

    Omaha, Nebraska, 68154, United States

  • New Jersey Urology LLC

    RECRUITING

    Voorhees Township, New Jersey, 08043, United States

  • Northwest Medical Specialties

    RECRUITING

    Tacoma, Washington, 98405, United States

  • Northwestern University

    RECRUITING

    Chicago, Illinois, 60611, United States

  • Novartis Investigative Site

    RECRUITING

    Darlinghurst, New South Wales, 2010, Australia

  • Novartis Investigative Site

    RECRUITING

    Adelaide, South Australia, 5000, Australia

  • Novartis Investigative Site

    RECRUITING

    Malvern, Victoria, 3144, Australia

  • Novartis Investigative Site

    RECRUITING

    Murdoch, Western Australia, 6150, Australia

  • Novartis Investigative Site

    RECRUITING

    Adelaide, 5000, Australia

  • Novartis Investigative Site

    RECRUITING

    São Paulo, São Paulo, 01308-050, Brazil

  • Novartis Investigative Site

    RECRUITING

    São Paulo, São Paulo, 05652-000, Brazil

  • Novartis Investigative Site

    RECRUITING

    Fuzhou, Fujian, 350025, China

  • Novartis Investigative Site

    RECRUITING

    Guangzhou, Guangdong, 510120, China

  • Novartis Investigative Site

    RECRUITING

    Guangzhou, Guangdong, 510632, China

  • Novartis Investigative Site

    RECRUITING

    Wuhan, Hubei, 430022, China

  • Novartis Investigative Site

    RECRUITING

    Wuhan, Hubei, 430030, China

  • Novartis Investigative Site

    RECRUITING

    Nanjing, Jiangsu, 210006, China

  • Novartis Investigative Site

    RECRUITING

    Nanjing, Jiangsu, 210029, China

  • Novartis Investigative Site

    RECRUITING

    Shenyang, Liaoning, 110011, China

  • Novartis Investigative Site

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • Novartis Investigative Site

    RECRUITING

    Hangzhou, Zhejiang, 310022, China

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100034, China

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100036, China

  • Novartis Investigative Site

    RECRUITING

    Guangzhou, 510060, China

  • Novartis Investigative Site

    RECRUITING

    Shanghai, 200025, China

  • Novartis Investigative Site

    RECRUITING

    Shanghai, 200032, China

  • Novartis Investigative Site

    RECRUITING

    Shanghai, 200127, China

  • Novartis Investigative Site

    RECRUITING

    Tianjin, 300300, China

  • Novartis Investigative Site

    RECRUITING

    Tianjin, 300480, China

  • Novartis Investigative Site

    RECRUITING

    Hong Kong, 999077, Hong Kong

  • Novartis Investigative Site

    RECRUITING

    Gurgaon, Haryana, 122 002, India

  • Novartis Investigative Site

    RECRUITING

    Bengaluru, Karnataka, 560066, India

  • Novartis Investigative Site

    RECRUITING

    Mumbai, Maharashtra, 400 012, India

  • Novartis Investigative Site

    RECRUITING

    Nagoya, Aichi-ken, 4668560, Japan

  • Novartis Investigative Site

    RECRUITING

    Sapporo, Hokkaido, 060-8648, Japan

  • Novartis Investigative Site

    RECRUITING

    Kobe, Hyōgo, 650-0017, Japan

  • Novartis Investigative Site

    RECRUITING

    Kobe, Hyōgo, 6500047, Japan

  • Novartis Investigative Site

    RECRUITING

    Yokohama, Kanagawa, 236-0004, Japan

  • Novartis Investigative Site

    RECRUITING

    Chuo Ku, Tokyo, 1040045, Japan

  • Novartis Investigative Site

    RECRUITING

    Chiba, 260-8717, Japan

  • Novartis Investigative Site

    RECRUITING

    Fukuoka, 811-0213, Japan

  • Novartis Investigative Site

    RECRUITING

    Fukuoka, 812-0033, Japan

  • Novartis Investigative Site

    RECRUITING

    Fukuoka, 8128582, Japan

  • Novartis Investigative Site

    RECRUITING

    Fukushima, 9601295, Japan

  • Novartis Investigative Site

    RECRUITING

    Hiroshima, 7348551, Japan

  • Novartis Investigative Site

    RECRUITING

    Kyoto, 6068507, Japan

  • Novartis Investigative Site

    RECRUITING

    Singapore, 119074, Singapore

  • Novartis Investigative Site

    RECRUITING

    Singapore, 168583, Singapore

  • Novartis Investigative Site

    RECRUITING

    Singapore, 169608, Singapore

  • Novartis Investigative Site

    RECRUITING

    Seoul, 01812, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seoul, 03080, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seoul, 03722, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seoul, 05505, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seoul, 06351, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seoul, 06591, South Korea

  • Novartis Investigative Site

    RECRUITING

    Kaohsiung City, 833, Taiwan

  • Novartis Investigative Site

    RECRUITING

    Taipei, 10002, Taiwan

  • Novartis Investigative Site

    RECRUITING

    Taoyuan, 33305, Taiwan

  • Novartis Investigative Site

    RECRUITING

    Sutton, Surrey, SM2 5PT, United Kingdom

  • Rocky Mountain Cancer Centers

    RECRUITING

    Denver, Colorado, 80218, United States

  • Sansum Clinic

    RECRUITING

    Santa Barbara, California, 93105, United States

  • Stanford University Medical Center

    RECRUITING

    Palo Alto, California, 94304, United States

  • Swedish Medical Center

    RECRUITING

    Seattle, Washington, 98122-4379, United States

  • Tennessee Oncology PLLC

    RECRUITING

    Chattanooga, Tennessee, 37404, United States

  • Univ Of Iowa Hospitals And Clinics

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University Cancer and Blood Center LLC

    RECRUITING

    Athens, Georgia, 30607, United States

  • University of Kansas Hospital

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Rochester Medical Ctr

    RECRUITING

    Rochester, New York, 14642, United States

  • Urology Centers Of Alabama Pc

    RECRUITING

    Homewood, Alabama, 35209, United States

  • Urology San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Wash U School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

  • Weill Cornell Medicine NY-Presb

    RECRUITING

    New York, New York, 10021, United States

  • Woodlands Cancer Institute American Oncology Partners

    RECRUITING

    The Woodlands, Texas, 77384, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.